WE ARE BIOCT


Industry Catalyst:
Elm Street Ventures helps power New Haven biotech boom

Chris McLeod, Managing Partner (left)
Rob Bettigole, Founder & Managing Partner (right)

EXCLUSIVE DISCOUNTS

New England Edge offers you substantial savings on the products and services you use the most.

Explore Offers

JOIN BIOCT

A diverse community of innovators committed to the growth and sustainability our bioscience community.

Join Now

EQUITY, DIVERSITY & INCLUSION

Be a part of the solution in helping find new ways to build inclusivity.

Learn More

CAREER CENTER

Your source for today’s talent, job opportunities and career development.

Career Center

BioCT is the voice of Connecticut’s bioscience industry.

Dedicated to the growth of a vibrant bioscience ecosystem, our organization connects companies, institutions, entrepreneurs, investors, government, service providers, and other passionate, dedicated people to improve patients’ lives and public health.

Upcoming Events

ABCT – Strengthening Your Application

You’ve decided to apply. Now work on getting invited! Learn how screeners respond to answers and how to improve your chance of admission. For more...

2
Academic Bioscience R&D
4
Bioscience Patents
561
NIH Funding in 2018
4
Bioscience Venture Capital
4
Most Innovative State
8
Science & Engineering Doctorates

BioCT is grateful for the support of our partners & sponsors.

Your exclusive member benefits.

We’ve partnered with MassBio to bring you an even-bigger purchasing program featuring the supplier discounts their members enjoy.
Save big on everything you need, from travel to office products to lab supplies and more.

Click for Discounts

BioCT’s catalyst for
innovation and entrepreneurship.

Innovation Commons is an incubator dedicated to talent development, job creation and the build of high value, sustainable businesses.

GOVERNMENT ADVOCACY

Your voice in Hartford
and Washington.

BioCT keeps policy makers abreast of the latest developments and changing needs of the bioscience community, ensuring policy alignment at the state and federal level.

Read More

Newsroom

Branford’s IsoPlexis makes Wall Street debut

IsoPlexis, a Branford-based life science technology company, went public in early October, with its stock initially trading at $15 a share. The company’s stock is listed...

Yale Blavatnik Fund eyes digital health

A five-year-old Yale program that has helped dozens of drug and medical device companies get their ideas off the ground is now looking to help...